Main Activity in Nanotechnology
Calibrant Biosystems, Inc. is a Gaithersburg, Maryland biotechnology company pioneering the discovery of novel protein targets and markers for the treatment and diagnosis of cancer. Calibrant’s unique approach to protein biomarker discovery applies the proprietary Gemini™ platform to the analysis of microdissected tissue specimens, enabling targeted and comprehensive evaluation of proteins within isolated tumor cells and their local microenvironment.
Calibrant partners with leading clinical research organizations to discover new therapeutic targets and biomarkers from microdissected archival tissue specimens within a range of cancer indications. Calibrant also partners with pharmaceutical and biotechnology companies seeking to leverage protein biomarkers during the drug development process by identifying novel therapeutic targets, reducing drug development times and attrition rates, and developing targeted drugs or repositioning existing compounds on the basis of effective patient stratification.
910 Clopper Road, Suite 220N